Indeed, tumor cells often overexpress acetyl-CoA carboxylase (ACACA), ATP citrate lyase (ACLY), and fatty acid synthase (FASN), key enzymes responsible for de novo biosynthesis of fatty acids, which makes them attractive targets for therapeutic interventions [14]. The gene discussed is ACLY; the disease is neoplasm.